The Early Results of the Laparoscopic Mini-Gastric Bypass/One Anastomosis Gastric Bypass on Patients with Different Body Mass Index

Table 2

Metabolic and nutritional state results of each BMI group from baseline to 6 months after the laparoscopic one anastomosis gastric bypass.

Variables (mean ± SD)	BMI groups (kg/m^2)	Normal laboratory reference range	Baseline (n = 50)	3 months (n = 50)	6 months (n = 50)	value	value
TG (mg/dL)	40–45	35–200	127.72 ± 51.58	119.32 ± 39.13	103.92 ± 42.797	<0.001	0.02
	45–50		183.00 ± 71.44	162.80 ± 68.30	137.88 ± 65.63	<0.001
TC (mg/dL)	40–45	Normal: <200; Borderline: 200–240; High risk: 240–400; Very high risk: >400	181.36 ± 37.50	160.24 ± 33.69	150.84 ± 22.99	<0.001	0.03
	45–50		209.08 ± 42.75	174.04 ± 21.13	156.60 ± 21.90	<0.001
HDL (mg/dL)	40–45	Men: >35; Women: >45; Desirable value: 40–60; Protect against CHD: >60; High risk for CHD: <20	47.32 ± 9.77	42.80 ± 5.17	44.40 ± 7.46	0.92	0.14
	45–50		54.08 ± 14.32	49.16 ± 10.52	45.52 ± 6.13	0.73
LDL (mg/dL)	40–45	Desirable: <130; Borderline: 130–160; High risk: >160	108.28 ± 32.46	99.32 ± 21.39	92.52 ± 16.87	0.44	0.59
	45–50		117.20 ± 25.46	109.64 ± 14.69	97.60 ± 14.50	0.29
Fe (mcg/dL)	40–45	60–150	87.88 ± 8.85	77.48 ± 21.75	81.64 ± 30.13	0.95	0.40
	45–50		92.08 ± 15.34	81.36 ± 12.41	89.08 ± 18.09	0.12
Ferritin (ng/mL)	40–45	20–200	65.20 ± 15.97	57.64 ± 26.66	59.20 ± 17.84	0.70	0.13
	45–50		65.08 ± 20.88	62.18 ± 23.29	64.68 ± 48.86	0.47
TIBC (mcg/dL)	40–45	240–450	257.76 ± 52.26	292.2 ± 47.57	304.56 ± 52.39	0.15	0.054
	45–50		280.88 ± 75.94	285.92 ± 65.66	298.40 ± 75.31	0.55
Vit B12 (pg/mL)	40–45	200–900	349.64 ± 112.06	342.68 ± 126.76	354.52 ± 107.18	0.44	0.03
	45–50		300.56 ± 63.82	310.52 ± 71.25	308.60 ± 63.68	0.53
Vit D (ng/mL)	40–45	Severe deficient: <10; Deficient: 10–30; Optimal level: 31–80; High normal: 91–99; Overdose: 100–150; Toxic: >150	40.20 ± 4.93	36.77 ± 5.89	37.80 ± 6.30	0.57	0.99
	45–50		38.13 ± 3.88	35.82 ± 6.50	35.78 ± 9.86	0.64
FBS (mg/dL)	40–45	Normal: <100; Prediabetes: 100–125; Diabetes: >125	96.60 ± 10.42	85.72 ± 8.44	82.12 ± 6.61	0.02	0.21
	45–50		103.72 ± 15.65	93.56 ± 11.41	84.76 ± 7.94	0.03
INR	40–45	<1.5	1.08 ± 0.11	1.10 ± 0.07	1.11 ± 0.06	0.43	0.53
	45–50		1.14 ± 0.14	1.12 ± 0.11	1.14 ± 0.09	0.33
Alb (g/dL)	40–45	3.5–5.5	4.47 ± 0.24	4.35 ± 0.31	4.29 ± 0.28	0.94	0.69
	45–50		4.54 ± 0.20	4.40 ± 0.19	4.31 ± 0.19	0.72
AST (IU/L)	40–45	<40	21.48 ± 5.35	18.28 ± 3.31	16.84 ± 3.14	0.60	0.61
	45–50		23.16 ± 5.24	19.64 ± 2.97	18.16 ± 3.68	0.57
ALT (IU/L)	40–45	Male: <40; Female: <30	25.60 ± 6.82	20.00 ± 4.97	16.92 ± 3.66	0.43	0.39
	45–50		25.56 ± 8.64	20.88 ± 5.34	18.72 ± 4.05	0.38
ALP (IU/L)	40–45	Female: 64–306; Male: 80–306	198.28 ± 18.32	192.20 ± 17.40	194.64 ± 17.92	0.29	0.47
	45–50		187.20 ± 27.43	184.04 ± 26.81	195.24 ± 19.53	0.66

TG, triglyceride; HDL, high-density lipoprotein; CHD, coronary high disease; LDL, low-density lipoprotein; TC, total cholesterol, Fe, iron; TIBC, total iron-binding capacity; Vit, vitamin; FBS, fasting blood glucose; INR, international normalized ratio; Alb, albumin; AST, aspartate aminotransferase; ALT, alanine aminotransferase; ALP, alkaline phosphatase; g: gram; mg: milligrams; ng: nanograms; mcg: micrograms; pg: picograms; L: liter; dL: deciliter; mL: milliliter; IU: international unit. value is the mean differences of each variable in each group data during the time and was calculated using ANOVA with repeated measures. value is the comparison of both the groups for each variable in multiple measures and was calculated with ANOVA. Indicates significant value.